Oncology Institute Inc (The)
TOI
Get informed when a big investor buys or sells
+ FollowMarket Cap$512.91M
Close$
$-4.71
191.8% downside
Current Fair Value
191.8% downsideOvervalued by 191.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $512.91 Million |
|---|---|
| Enterprise Value | $496.43 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.54 |
| Beta | 0.42 |
| Outstanding Shares | 1,030,314,930 |
Return
| Return on Equity | 145.67% |
|---|---|
| Return on Assets | -20.36% |
| Return on Invested Capital | -31.32% |
Valuation & Multiples
| P/E Ratio | -21.55 |
|---|---|
| PEG | 50.77 |
| Price to Sales | - |
| Price to Book Ratio | -5.13 |
| Enterprise Value to Revenue | 0.85 |
| Enterprise Value to EBIT | -19.03 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | -0.99 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$155.21 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0653▲ 4.75% |
|---|---|
| Total Calls | 2,425,900▼ 34.11% |
| Total Puts | 158,300▲ 142.79% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.81%▼ 0.36% |
|---|---|
| Total Invested | $118.92M▼ 13.27% |
| Investors Holding | 120▼ 2.00% |
ESG Score
No data